Security key
67080T108
- Type / Class
- Equity / COM
- Total 13F shares
- 1,252,927
- Share change
- +768,999
- Total reported value
- $20,033,227
- Price per share
- $15.97
- Number of holders
- 37
- Value change
- +$12,444,259
- Number of buys
- 35
- Number of sells
- 5
Report period
Q2 2023
Institutions
37
Top holders
10
NVCT full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Nuvectis Pharma, Inc. SEC filings
Nuvectis Pharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 67080T108
Recent filing periods:
Top shareholders of NVCT - Nuvectis Pharma, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
—
class O/S missing
|
201,433
|
$2,640,786 | — | 31 Mar 2023 | |
| BALDWIN WEALTH PARTNERS LLC/MA |
13F
|
Company |
—
class O/S missing
|
143,800
|
$1,885,218 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
35,022
|
$459,138 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
24,667
|
$323,000 | — | 31 Mar 2023 | |
| EDMOND DE ROTHSCHILD HOLDING S.A. |
13F
|
Company |
—
class O/S missing
|
24,570
|
$322,113 | — | 31 Mar 2023 | |
| Uri Ben-Or |
3/4/5
|
Int. Principal Financial Off. |
—
class O/S missing
|
25,584
|
$283,471 | — | 08 Feb 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
—
class O/S missing
|
13,556
|
$177,720 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
—
class O/S missing
|
13,400
|
$175,674 | — | 31 Mar 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
—
class O/S missing
|
11,086
|
$145,337 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
—
class O/S missing
|
3,115
|
$40,838 | — | 31 Mar 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
class O/S missing
|
250
|
$3,000 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
class O/S missing
|
164
|
$2,150 | — | 31 Mar 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
—
class O/S missing
|
25
|
$328 | — | 31 Mar 2023 |
Institutional Holders of Nuvectis Pharma, Inc. - COM (NVCT) as of Q2 2023
As of 30 Jun 2023,
Nuvectis Pharma, Inc. - COM (NVCT) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,252,927 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, BALDWIN BROTHERS LLC/MA, FORBES J M & CO LLP, NORTHERN TRUST CORP, MARSHALL WACE, LLP, RENAISSANCE TECHNOLOGIES LLC, and CITADEL ADVISORS LLC.
This page lists
37
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
13
Q2 2023 holders
37
Holder diff
24
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.